Dr. Sharvina Ziyeh, MD

Dr. Ziyeh practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Ziyeh's NPI, 1790272367, was assigned on April 18, 2018. Dr. Ziyeh graduated from Saint Louis University School Of Medicine in 2018. Dr. Ziyeh's California license number on file is A166738.

Dr. Ziyeh's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Ziyeh's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Ziyeh is also affiliated with Olive View-UCLA Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Ziyeh to 3 more hospitals, 1 group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ziyeh practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ziyeh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ziyeh is board certified in internal medicine by the American Board of Internal Medicine. Dr. Ziyeh has a license on file in California.

CMS data shows 104 Medicare services from Dr. Ziyeh across 4 procedure codes in 2024, all of them office visits, for 61 Medicare patients. Medicare paid $11,112 for them. Every service was in an office.

CMS counts 61 Medicare patients who saw Dr. Ziyeh in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ziyeh's median patient age at 67, with 72% women.

In 2024, Dr. Ziyeh wrote 202 Medicare Part D claims for 53 patients. 69% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $896 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Ziyeh for performance year 2024, reported as part of a group. Dr. Ziyeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ziyeh as offering telehealth.

Dmand AI links 5 papers to Dr. Ziyeh, published from 2015 to 2024. The most frequent topics are Breast Neoplasms. Dr. Ziyeh's most frequent co-authors are Natasha Banerjee, MD, Reva Kakkar Basho, MD and Tanios S. Bekaii-Saab, MD.

CMS Open Payments shows 82 general payments to Dr. Ziyeh from 23 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 87% of the total. Seagen Inc. paid the most, $1,246.

Dr. Ziyeh graduated from Saint Louis University School Of Medicine in 2018.

Dr. Ziyeh is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.